Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Uniqure
Uniqure
(QURE)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Glybera
Alipogene tiparvovec
2012-10-25
Hyperlipoproteinemia type i
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Alipogene tiparvovec
hyperlipoproteinemia type i
,
hyperlipidemias
,
hyperlipoproteinemias
Mycophenolate sodium
healthy volunteers/patients
Orgotein
amyotrophic lateral sclerosis
,
motor neuron disease
,
sclerosis
Alfacalcidol
dermatomyositis
,
ulcerative colitis
,
hyperparathyroidism
,
secondary hyperparathyroidism
,
neoplasm metastasis
,
chronic renal insufficiency
,
left ventricular hypertrophy
,
kidney diseases
,
cardiomegaly
,
hypertrophy
Bevifimod
hot flashes
,
healthy volunteers/patients
,
fibromyalgia
Lotamilast
amyotrophic lateral sclerosis
,
motor neuron disease
,
sclerosis
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
parkinson disease
,
respiratory tract infections
,
infections
,
communicable diseases
,
drug-related side effects and adverse reactions
,
kidney transplantation
Remetinostat
amyotrophic lateral sclerosis
,
motor neuron disease
,
sclerosis
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
parkinson disease
,
respiratory tract infections
,
infections
,
communicable diseases
,
drug-related side effects and adverse reactions
,
kidney transplantation
Usistapide
liver failure
,
hepatic insufficiency
,
renal insufficiency
,
hypertension
,
hepatitis c
,
hepatitis
,
hepatitis a
,
neoplasms
,
overactive urinary bladder
,
parkinson disease
,
central nervous system diseases
,
brain diseases
,
movement disorders
,
neurodegenerative diseases
,
head and neck neoplasms
,
cough
,
schizophrenia
,
nervous system diseases
,
carcinoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
squamous cell neoplasms
,
leukemia
,
myelodysplastic syndromes
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia
,
preleukemia
,
blast crisis
,
lymphoid leukemia
,
melanoma
,
colorectal neoplasms
,
non-small-cell lung carcinoma
,
esophageal neoplasms
,
panic disorder
,
alcoholism
,
postoperative pain
,
osteoarthritis
,
neuralgia
,
postherpetic neuralgia
,
general anesthesia
,
glioblastoma
,
astrocytoma
,
anesthesia
,
muscle relaxation
,
delayed emergence from anesthesia
Solumedrol
arteritis
,
giant cell arteritis
,
ischemic optic neuropathy
,
polymyalgia rheumatica
,
behcet syndrome
,
bullous pemphigoid
,
asthma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
lupus nephritis
,
non-hodgkin lymphoma
,
systemic lupus erythematosus
,
kidney transplantation
,
membranous glomerulonephritis
,
multiple sclerosis
,
chronic progressive multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
nephritis
,
prostatic neoplasms
,
neuromyelitis optica
,
kidney diseases
,
anti-neutrophil cytoplasmic antibody-associated vasculitis
,
end stage liver disease
,
nephrotic syndrome
,
rheumatoid arthritis
,
lymphoma
,
follicular lymphoma
,
granulomatosis with polyangiitis
,
microscopic polyangiitis
,
liver transplantation
,
heart transplantation
,
arthritis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use